1. American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update
2. New cancer therapies and jaw necrosis
3. Scottish Dental Clinical Effectiveness Programme. Oral health management of patients at risk of medication-related osteonecrosis of the jaw: dental clinical guidance. 2017. http://www.sdcep.org.uk/wp-content/uploads/2017/04/SDCEP-Oral-Health-Management-of-Patients-at-Risk-of-MRONJ-Guidance-full.pdf.
4. MRONJ risk of adjuvant bisphosphonates in early stage breast cancer
5. Medicines and Healthcare products Regulatory Agency. Bevacizumab and sunitinib: risk of osteonecrosis of the jaw. Drug Safety Update. 2014. https://www.gov.uk/drug-safety-update/bevacizumab-and-sunitinib-risk-of-osteonecrosis-of-the-jaw.